Most Comprehensive Study Ever of Deadly Hypertrophic Cardiomyopathy (IMAGE)
Caption
The early findings from the $14.4 million study suggest that patients can largely be grouped into two buckets: Patients with a clearly defined genetic mutation tended to have more scarring of the heart muscle, while patients without such a mutation tended to have no scar and more obstruction of blood flow, said UVA Health's Christopher M. Kramer, MD.
Credit
Dan Addison | UVA Communications
Usage Restrictions
May be used to accompany news coverage of this specific study. All other uses require express written permission from UVA Health.
License
Licensed content